Edges in Network
Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | APOA2 |
Upstream (Parents) |
---|
(<<) NSUN7 → APOA2 |
(<<) DHRS9 → APOA2 |
(<<) TNFRSF10C → APOA2 |
(<<) RPL21P80///RPL21P87///RPL21P37///RPL21P18///RPL21P16///RPL21P14///RPL21P134///RPL21P45///RPL21P119///RPL21P93///RPL21P98///RPL21P82///RPL21P46///RPL21P61///RPL21P69///RPL21P19///RPL21P62///RPL21P29///RPL21P44///RPL21P39///RPL21P97///RPL21 → APOA2 |
(<<) NTRK3 → APOA2 |
(<<) NLGN3 → APOA2 |
(<<) C2orf56 → APOA2 |
(<<) AKAP9 → APOA2 |
(<<) ACSF2 → APOA2 |
Downstream (Children) |
---|
APOA2 → WDR59 (>>) |
APOA2 → TNFRSF10C (>>) |
APOA2 → RPL21P80///RPL21P87///RPL21P37///RPL21P18///RPL21P16///RPL21P14///RPL21P134///RPL21P45///RPL21P119///RPL21P93///RPL21P98///RPL21P82///RPL21P46///RPL21P61///RPL21P69///RPL21P19///RPL21P62///RPL21P29///RPL21P44///RPL21P39///RPL21P97///RPL21 (>>) |